Neurology® Podcast

In the first segment, Dr. Jeff Ratliff talks with Dr. Nico Dosenbach about his Neuron paper on neural networks and deep brain stimulation, and they specifically cover the Neurology Today article on this paper with respect to the impact on DBS. In the second part of the podcast, Dr. Jeff Ratliff speaks with Dr. Alberto Espay about his paper—from the March 17th issue of Neurology—on reconsidering biomarkers in Parkinson disease. You can read the Neurology Today story here: https://bit.ly/2TzJr0Y; and you can read the Neuron paper here: https://bit.ly/2TX1zku.

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week's Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Dr. Ian Lipkin discusses his own diagnosis with COVID-19 and what neurologists can do in light of the pandemic to keep safe and to serve patients. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

Find the cast of Contagion's PSAs on the pandemic: https://abcnews.go.com/Entertainment/cast-contagion-issues-psa-coronavirus-pandemic/story?id=69853838.

Find Columbia University's Control the Contagion page: https://www.publichealth.columbia.edu/controlthecontagion.

In the first segment, Dr. Jason Crowell talks with Dr. Daniel Hartung about his paper on the effect of generic glatiramer acetate on the reduction of MS costs. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Brian Callaghan about his paper—also from the March 31st issue of Neurology—on the association between out-of-pocket costs and adherence to common neurologic medications.

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week's Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Dr. Avindra Nath provides a special report on what clinicians need to know about neurologic symptoms and complications of COVID-19.

For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

In the first segment, Dr. Matthew Barrett talks with Dr. John-Paul Taylor about his paper on Lewy body dementia management, from The Lancet. In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Chris Butler about his paper on pathologic tearfulness after limbic encephalitis. You can read Dr. Taylor's paper in The Lancet here: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30153-X/fulltext.

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week's Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Dr. Jason Crowell speaks with Dr. John Noseworthy on his NEJM article on preserving the physician-patient relationship, which you can read here: https://www.nejm.org/doi/full/10.1056/NEJMsr1912662.

Dr. Halley Alexander talks with Dr. Emma Foster about her Neurology paper discussing that antiepileptic drugs are not independently associated with cognitive dysfunction.

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week's Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Dr. Jason Crowell speaks with Denise Roland of the Wall Street Journal about her story on an obscure model driving down drug costs. You can read their paper in the Wall Street Journal here: https://www.wsj.com/articles/obscure-model-puts-a-price-on-good-healthand-drives-down-drug-costs-11572885123.

This month's Delayed Recall highlights 6 interviews on encephalopathies from the March and April 2013 Delayed Recall episodes. You'll hear about encephalopathies caused by endocrine disorders, by electrolyte disorders, by liver and kidney failure, and by other organ failure. The other interviews cover encephalopathies caused by systemic disease, such as encephalopathies caused by drugs or miscellaneous causes, including vitamin deficiencies and autoimmune disorders.

Dr. Stacey Clardy talks with Dr. Robert Silbergleit and Dr. Jaideep Kapur about anticonvulsant medications for status epilepticus. You can read Dr. Silbergleit and Dr. Kapur's paper in the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMoa1905795.